Drug Costs Archives - Page 24 of 35

Podcast: KHN’s ‘What The Health?’ (Almost) Live from Austin!

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Ollstein of Politico talk about how health issues will play in midterm elections, the Trump administration’s move that could penalize legal immigrants who use government aid programs, and other topics. Due to technical difficulties, the original discussion taped Sept. 27 at the 2018 Texas Tribune Festival could not be broadcast, so the panelists reconvened from Austin and Washington on Sept. 28.

Sept. 28, 2018

Buried In Congress’ Opioid Bill Is Protection For Personal Drug Imports

The protection is a win for people who get their needed, legitimate drugs from overseas.

By Michael McAuliff

Sept. 27, 2018

Letters To The Editor

Readers And Tweeters Slice And Dice Precision Medicine, Step Therapy

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Sept. 26, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Sept. 21, 2018

As States Try To Rein In Drug Spending, Feds Slap Down One Bold Medicaid Move

Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.

By Martha Bebinger, WBUR

Sept. 21, 2018

New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients’ Choices

Federal officials are allowing the private insurance plans to use “step therapy” for drugs administered by doctors. In step therapy, patients must first use cheaper drugs to see if they work before receiving more expensive options.

By Susan Jaffe

Sept. 17, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Sept. 14, 2018

Unwitting Patients, Copycat Comments Play Hidden Role In Federal Rule-Making

As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.

By Sarah Jane Tribble

Sept. 11, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Sept. 7, 2018

Insulin’s Steep Price Leads To Deadly Rationing

Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn't afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.

By Bram Sable-Smith, Side Effects Public Media

Sept. 7, 2018

The High Cost Of Hope: When The Parallel Interests Of Pharma And Families Collide

Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.

By Emily Kopp and Jay Hancock

Sept. 7, 2018

Lawmakers Push To Protect Patients And Counter Trump

California legislators approved some significant health care proposals in their rush to meet the Friday end-of-session deadline. They tackled controversial topics, such as making abortion pills available on college campuses, and adopted measures countering Trump administration attacks on the Affordable Care Act.

By Samantha Young

Sept. 4, 2018

Podcast: KHN’s ‘What The Health?’ Ask Us Anything!

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico answer listeners’ questions about health policy and politics.

Aug. 30, 2018

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Aug. 10, 2018

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.

By Sarah Jane Tribble

Aug. 10, 2018

Podcast: KHN’s ‘What The Health?’ Coming Soon: ‘Long-Term Short-Term’ Plans

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.

Aug. 9, 2018

Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk

Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.

By Julie Appleby

Aug. 9, 2018

Medicaid Expansion Making Diabetes Meds More Accessible To Poor, Study Shows

The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.

By Pauline Bartolone

Aug. 6, 2018

Must-Reads Of The Week From Brianna Labuskes

KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Aug. 3, 2018

To Tame Prescription Prices, HHS Dips A Toe Into Drug Importation Stream

The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.

By Rachel Bluth

Aug. 1, 2018

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drug Costs